Fond. Ist. S. Raffaele - giglio

Cefalù, Sicily 90015

0 studies enrolling now · 2 studies all time

What they study most

NMO Spectrum Disorder (NMOSD), Neuromyelitis Optica (NMO), Relapsing Multiple Sclerosis

Studies at this site

• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) — Completed